839
CONCLUSION: Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and deterioration of pulmonary function following the use of tobramycin by inhalation or by intravenous administration.
 patients: Subject; recurrent eosinophilia and deterioration of pulmonary function: Effect; use of tobramycin by inhalation or by intravenous administration: Treatment; tobramycin: Treatment.Drug; inhalation: Treatment.Route; intravenous administration.: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients: Subject; recurrent eosinophilia and deterioration of pulmonary function: Effect; use of tobramycin by inhalation or by intravenous administration: Treatment; tobramycin: Treatment.Drug; inhalation: Treatment.Route; intravenous administration.: Treatment.Route